Clinitech Laboratory Ltd

Clinitech Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Clinitech Laboratory Ltd

₹ 39.5 0.77%
12 Dec - close price
ctllab.in BSE - SME: 544220
About

Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.[1]

Key Points

Business Overview:[1]
CTLL in the business of providing NABL
accredited healthcare services such as:
a) Pathology testing labs
b) Diagnostic centres
c) Scan centres
d) X-ray centres
e) ECG clinics

Website BSE
  • Market Cap ₹ 9.02 Cr.
  • Current Price ₹ 39.5
  • High / Low ₹ 99.0 / 29.2
  • Stock P/E 19.2
  • Book Value ₹ 40.0
  • Dividend Yield 0.00 %
  • ROCE 8.15 %
  • ROE 5.49 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.99 times its book value
  • Promoter holding has increased by 0.84% over last quarter.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 11.6% over last 3 years.
  • Earnings include an other income of Rs.0.28 Cr.
  • Debtor days have increased from 43.6 to 68.3 days.
  • Working capital days have increased from 34.4 days to 115 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
3.06 3.34 4.08 4.16 5.08
2.78 2.61 3.52 3.88 4.54
Operating Profit 0.28 0.73 0.56 0.28 0.54
OPM % 9.15% 21.86% 13.73% 6.73% 10.63%
0.02 0.01 0.05 0.17 0.11
Interest 0.04 0.06 0.04 0.02 0.05
Depreciation 0.19 0.25 0.31 0.14 0.25
Profit before tax 0.07 0.43 0.26 0.29 0.35
Tax % 14.29% 30.23% 15.38% 41.38% 14.29%
0.07 0.30 0.22 0.17 0.30
EPS in Rs 0.47 1.79 0.96 0.74 1.31
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
4.55 6.38 6.35 6.40 8.23 9.24
3.72 5.31 4.99 5.41 7.40 8.42
Operating Profit 0.83 1.07 1.36 0.99 0.83 0.82
OPM % 18.24% 16.77% 21.42% 15.47% 10.09% 8.87%
0.04 0.07 0.02 0.04 0.23 0.28
Interest 0.08 0.06 0.07 0.09 0.06 0.07
Depreciation 0.25 0.38 0.45 0.44 0.45 0.39
Profit before tax 0.54 0.70 0.86 0.50 0.55 0.64
Tax % 25.93% 27.14% 29.07% 26.00% 29.09%
0.40 0.51 0.61 0.37 0.39 0.47
EPS in Rs 6.00 3.40 4.07 2.20 1.71 2.05
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 9%
TTM: 25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -13%
TTM: -10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -49%
Return on Equity
10 Years: %
5 Years: %
3 Years: 12%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.67 1.50 1.50 1.68 2.28 2.28
Reserves 0.72 0.35 0.88 1.87 6.55 6.85
0.54 0.89 1.03 0.87 0.00 0.17
0.80 0.94 2.62 1.19 1.88 1.83
Total Liabilities 2.73 3.68 6.03 5.61 10.71 11.13
0.84 1.65 1.33 1.71 2.12 2.90
CWIP 0.08 0.41 0.56 0.94 1.01 0.00
Investments 0.09 0.14 2.02 0.07 0.07 0.07
1.72 1.48 2.12 2.89 7.51 8.16
Total Assets 2.73 3.68 6.03 5.61 10.71 11.13

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.38 0.96 1.25 -1.28 -0.88
0.54 -1.47 -0.65 0.75 -0.73
-0.88 0.29 0.09 0.45 3.98
Net Cash Flow 0.04 -0.22 0.68 -0.08 2.37

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 44.92 20.60 28.17 34.22 68.30
Inventory Days 32.21 40.28 43.68 92.91 124.01
Days Payable 164.61 130.90 124.79 116.14 147.40
Cash Conversion Cycle -87.48 -70.03 -52.95 10.99 44.90
Working Capital Days 43.32 -4.58 -33.34 21.67 114.87
ROCE % 32.55% 30.24% 14.81% 8.15%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2024Mar 2025Sep 2025
61.58% 61.58% 62.42%
0.32% 0.32% 0.32%
38.11% 38.11% 37.27%
No. of Shareholders 346303303

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports